Solana (HSDT) Directors and Executive Officers

Officers & Directors

Jeffrey S. Mathiesen
Baker Tilly US, LLP
We have served as the Company’s auditor

Dane C. Andreeff
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act

Sherrie Perkins

Paul Buckman

Blane Walter

Edward M. Straw ,

Solana Company currently has 21 employees.

News about Solana Company Key Personnel

Helius Medical Technologies Announces Inducement Grants Amidst Negative Financial Performance and Share Price Decline,

Helius Medical Technologies, Inc. Announces Inducement Grants and Reports Negative Return on Investment
NEWTON, Pa., Aug. 16, 2024 - Helius Medical Technologies, Inc. (Nasdaq: HSDT), a leading neurotech company focused on neurological wellness, announced today that it has approved equity awards under Helius 2021 Inducement Plan as a material inducement to three new hires. The approval was made by the company s independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which requires a public announcement of equity awards not made under a stockholder-approved equity plan.
The new equity awards, effective August 14, 2024, demonstrate Helius commitment to attracting and retaining top...

Breakthrough Neurorehabilitation Therapy Shows Promise in Stroke Treatment

Introduction
Helius Medical Technologies, Inc. has reached a significant milestone in its U.S. Registrational Program in Stroke, announcing the completion of site participation enrollment. This groundbreaking program aims to revolutionize stroke rehabilitation using the innovative Portable Neuromodulation Stimulator (PoNS) Therapy. The inclusion of renowned neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions highlights the growing recognition and potential of this therapy. Furthermore, a complementary study on the use of PoNS Therapy in Canada is underway, with the goal of supporting reimbursement in Canada and gaining U.S. approval for s...